FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093833738> ?p ?o ?g. }

• W3093833738 endingPage "e001642" @default.
• W3093833738 startingPage "e001642" @default.
• W3093833738 abstract "Introduction Differences in mortality and cause-specific mortality rates according to glycated albumin (GA) and hemoglobin A1c (HbA1c) levels among dialysis patients with diabetes based on hypoglycemic agent use and malnutrition status remain unclear. Here, we examine these associations using a nationwide cohort. Research design and methods We examined 40 417 dialysis patients with diabetes who met our inclusion criteria (female, 30.8%; mean age, 67.3±11.2 years; mean dialysis duration, 5.4±4.6 years). The Global Leadership Initiative on Malnutrition criteria were used to assess malnutrition. Adjusted HRs and 95% confidence limits were calculated for 3-year mortality after adjustment for 18 potential confounders. HRs and subdistribution HRs were used to explore cause-specific mortality. Results We found a linear association between 3-year mortality and GA levels only in patients with GA ≥18% and not in patients with low GA levels, with a U-shaped association between HbA1c levels and the lowest morality at an HbA1c 6.0%–6.3%. This association differed based on patient conditions and hypoglycemic agent use. If patients using hypoglycemic agents were malnourished, mortality was increased with GA ≥24% and HbA1c ≥8%. In addition, patients with GA ≥22% and HbA1c ≥7.6% had significantly higher infectious or cardiovascular mortality rates. On the other hand, an inverse association was found between GA or HbA1c levels and cancer mortality. Patients with GA ≤15.8% had a higher risk of cancer mortality, especially those not using hypoglycemic agents (HR 1.63 (1.00–2.66)). Conclusions Target GA and HbA1c levels in dialysis patients may differ according to hypoglycemic agent use, nutritional status, and the presence of cancer. The levels may be higher in malnourished patients than in other patients, and a very low GA level in dialysis patients not taking hypoglycemic agents may be associated with a risk of cancer. Trial registration number UMIN000018641." @default.
• W3093833738 created "2020-10-29" @default.
• W3093833738 creator A5000401675 @default.
• W3093833738 creator A5000927500 @default.
• W3093833738 creator A5001104972 @default.
• W3093833738 creator A5004884368 @default.
• W3093833738 creator A5024728176 @default.
• W3093833738 creator A5027562890 @default.
• W3093833738 creator A5042503159 @default.
• W3093833738 creator A5048362779 @default.
• W3093833738 creator A5066803512 @default.
• W3093833738 creator A5074805331 @default.
• W3093833738 date "2020-10-01" @default.
• W3093833738 modified "2023-10-10" @default.
• W3093833738 title "Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study" @default.
• W3093833738 cites W1537173512 @default.
• W3093833738 cites W1877321878 @default.
• W3093833738 cites W1972147248 @default.
• W3093833738 cites W1973617793 @default.
• W3093833738 cites W2010444648 @default.
• W3093833738 cites W2044548765 @default.
• W3093833738 cites W2046397974 @default.
• W3093833738 cites W2099758743 @default.
• W3093833738 cites W2109819974 @default.
• W3093833738 cites W2144674423 @default.
• W3093833738 cites W2145755811 @default.
• W3093833738 cites W2148890475 @default.
• W3093833738 cites W2156934515 @default.
• W3093833738 cites W2160663184 @default.
• W3093833738 cites W2163687719 @default.
• W3093833738 cites W2530541894 @default.
• W3093833738 cites W2591361690 @default.
• W3093833738 cites W2604505668 @default.
• W3093833738 cites W2626131515 @default.
• W3093833738 cites W2776692548 @default.
• W3093833738 cites W2789811380 @default.
• W3093833738 cites W2792480713 @default.
• W3093833738 cites W2797428003 @default.
• W3093833738 cites W2968244898 @default.
• W3093833738 cites W4231015464 @default.
• W3093833738 doi "https://doi.org/10.1136/bmjdrc-2020-001642" @default.
• W3093833738 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7590349" @default.
• W3093833738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33099507" @default.
• W3093833738 hasPublicationYear "2020" @default.
• W3093833738 type Work @default.
• W3093833738 sameAs 3093833738 @default.
• W3093833738 citedByCount "8" @default.
• W3093833738 countsByYear W30938337382021 @default.
• W3093833738 countsByYear W30938337382022 @default.
• W3093833738 countsByYear W30938337382023 @default.
• W3093833738 crossrefType "journal-article" @default.
• W3093833738 hasAuthorship W3093833738A5000401675 @default.
• W3093833738 hasAuthorship W3093833738A5000927500 @default.
• W3093833738 hasAuthorship W3093833738A5001104972 @default.
• W3093833738 hasAuthorship W3093833738A5004884368 @default.
• W3093833738 hasAuthorship W3093833738A5024728176 @default.
• W3093833738 hasAuthorship W3093833738A5027562890 @default.
• W3093833738 hasAuthorship W3093833738A5042503159 @default.
• W3093833738 hasAuthorship W3093833738A5048362779 @default.
• W3093833738 hasAuthorship W3093833738A5066803512 @default.
• W3093833738 hasAuthorship W3093833738A5074805331 @default.
• W3093833738 hasBestOaLocation W30938337381 @default.
• W3093833738 hasConcept C126322002 @default.
• W3093833738 hasConcept C134018914 @default.
• W3093833738 hasConcept C201903717 @default.
• W3093833738 hasConcept C2777180221 @default.
• W3093833738 hasConcept C2777538456 @default.
• W3093833738 hasConcept C2778063415 @default.
• W3093833738 hasConcept C2779056158 @default.
• W3093833738 hasConcept C2779978075 @default.
• W3093833738 hasConcept C551997983 @default.
• W3093833738 hasConcept C555293320 @default.
• W3093833738 hasConcept C71924100 @default.
• W3093833738 hasConcept C72563966 @default.
• W3093833738 hasConcept C77350462 @default.
• W3093833738 hasConceptScore W3093833738C126322002 @default.
• W3093833738 hasConceptScore W3093833738C134018914 @default.
• W3093833738 hasConceptScore W3093833738C201903717 @default.
• W3093833738 hasConceptScore W3093833738C2777180221 @default.
• W3093833738 hasConceptScore W3093833738C2777538456 @default.
• W3093833738 hasConceptScore W3093833738C2778063415 @default.
• W3093833738 hasConceptScore W3093833738C2779056158 @default.
• W3093833738 hasConceptScore W3093833738C2779978075 @default.
• W3093833738 hasConceptScore W3093833738C551997983 @default.
• W3093833738 hasConceptScore W3093833738C555293320 @default.
• W3093833738 hasConceptScore W3093833738C71924100 @default.
• W3093833738 hasConceptScore W3093833738C72563966 @default.
• W3093833738 hasConceptScore W3093833738C77350462 @default.
• W3093833738 hasFunder F4320313844 @default.
• W3093833738 hasIssue "1" @default.
• W3093833738 hasLocation W30938337381 @default.
• W3093833738 hasLocation W30938337382 @default.
• W3093833738 hasOpenAccess W3093833738 @default.
• W3093833738 hasPrimaryLocation W30938337381 @default.
• W3093833738 hasRelatedWork W2023255092 @default.
• W3093833738 hasRelatedWork W2026810754 @default.
• W3093833738 hasRelatedWork W2065091400 @default.
• W3093833738 hasRelatedWork W2481749367 @default.

• next